Author

Hanlan Liu

ORCID 0009-0003-7724-9103Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Adam S. Lazorchak· 1 shared Amy Lundberg· 1 shared Anja F. Hohmann· 1 shared C D Malloy· 1 shared Caroline P. Bullock· 1 shared Charuta Yadav· 1 shared Christopher M. Scull· 1 shared Cícera Regina LazzarottoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Adam S. Lazorchak

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyMolecular TherapyPeer-reviewedSep 5, 2025

A Precision Gene Engineered B Cell Medicine Producing Sustained Levels of Active Factor IX for Hemophilia B Therapy

Hanlan Liu, Swati Singh, Timothy Mullen…·Richard A. Morgan

This paper describes a gene-engineered B Cell Medicine (BE-101) that produces sustained active factor IX for hemophilia B therapy, showing durable and redosable effects in mice.

8 citationstop 3%

mouseexperimental assay

𝕏 PostBluesky